Cosmos Health Inc.: shareholders and insiders

COSMNASDAQHealthcare · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Price

$2.87

November 19, 2026

What Ploutos Investor adds for Cosmos Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 13 fiscal years, from 2013
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 1,286% since Aug 18, 2026, when the 10-Q these figures come from was filed ($0.21 then, $2.87 on Nov 19, 2026). The figures date from before that move.10-Q
  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 20, 2025 to Jul 31, 2026, from their own Form 4 filings.

13 Form 4s

Bought on the market

$1.7M

2 people

Sold on the market

–

nobody

From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $1.4M by 2 people·no sales

  • 2025: bought $268.0K by 1 person, no sales
  • 2026: bought $1.4M by 2 people, no sales
  • Grigorios SiokasChief Executive Officer
    Kind
  • Georgios TerzisChief Financial Officer
    Kind
  • Grigorios SiokasChief Executive Officer
    Kind
  • Georgios TerzisChief Financial Officer
    Kind
  • Grigorios SiokasChief Executive Officer
    Kind
  • Grigorios SiokasChief Executive Officer
    Kind
  • Theodoros Christos KarkantzosDirector
    Kind
  • John James HoidasDirector
    Kind
  • Demetrios G. DemetriadesSecretary
    Kind
  • Anastasios AslidisDirector
    Kind
  • Suhel BhutawalaDirector
    Kind
  • Georgios TerzisChief Financial Officer
    Kind
  • Grigorios SiokasChief Executive Officer
    Kind
  • Feb 12, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Feb 11, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Jan 23, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Jan 20, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Jan 14, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Jan 12, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Jan 8, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Jan 7, 2026Grigorios SiokasChief Executive Officer
    Kind
  • Jan 6, 2026Grigorios SiokasChief Executive Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 11, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by COSM's officers and directors from 2012 up to November 19, 2025, 14 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%1 On a 13DNov 12, 2026 Latest filing
  • Grigorios Siokas
    Share of class22.9%
  • Bovopoulos Andreas
    Share of class8.10%
  • Wells Fargo & Company
    Share of class5.10%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Grigorios Siokas22.9%From the filing of May 27, 2025

    There are no plans or proposals which the reporting person has which may result in any of the matters listed.

    From the filing of May 27, 2025
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Armistice Capital, LLC4.99%Aug 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter
  • Renaissance Technologies
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 2.27% of its shares outstanding were held short, -10.7% since the report before.

Shares held short
2.29M
2.27%
Since the report before2.56M on Sep 30, 2026
-10.7%
under 1
2.93M
More days to cover thanof 4,578 US-listed companies with enough volume
15%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 197.1K
  • Nov 15, 2023: Shares held short 171.9K
  • Nov 30, 2023: Shares held short 90.7K
  • Dec 15, 2023: Shares held short 135.0K
  • Dec 29, 2023: Shares held short 332.1K
  • Jan 12, 2024: Shares held short 117.9K
  • Jan 31, 2024: Shares held short 202.2K
  • Feb 15, 2024: Shares held short 423.2K
  • Feb 29, 2024: Shares held short 406.2K
  • Mar 15, 2024: Shares held short 189.7K
  • Mar 28, 2024: Shares held short 547.8K
  • Apr 15, 2024: Shares held short 444.8K
  • Apr 30, 2024: Shares held short 345.6K
  • May 15, 2024: Shares held short 332.2K
  • May 31, 2024: Shares held short 371.3K
  • Jun 14, 2024: Shares held short 305.9K
  • Jun 28, 2024: Shares held short 761.5K
  • Jul 15, 2024: Shares held short 284.1K
  • Jul 31, 2024: Shares held short 172.9K
  • Aug 15, 2024: Shares held short 127.1K
  • Aug 30, 2024: Shares held short 642.3K
  • Sep 13, 2024: Shares held short 428.0K
  • Sep 30, 2024: Shares held short 651.6K
  • Oct 15, 2024: Shares held short 568.5K
  • Oct 31, 2024: Shares held short 363.5K
  • Nov 15, 2024: Shares held short 371.4K
  • Nov 29, 2024: Shares held short 460.9K
  • Dec 13, 2024: Shares held short 350.3K
  • Dec 31, 2024: Shares held short 537.8K
  • Jan 15, 2025: Shares held short 881.6K
  • Jan 31, 2025: Shares held short 531.9K
  • Feb 14, 2025: Shares held short 571.9K
  • Feb 28, 2025: Shares held short 804.0K
  • Mar 14, 2025: Shares held short 646.9K
  • Mar 31, 2025: Shares held short 629.6K
  • Apr 15, 2025: Shares held short 507.7K
  • Apr 30, 2025: Shares held short 184.0K
  • May 15, 2025: Shares held short 436.7K
  • May 30, 2025: Shares held short 210.6K
  • Jun 13, 2025: Shares held short 492.6K
  • Jun 30, 2025: Shares held short 444.9K
  • Jul 15, 2025: Shares held short 423.3K
  • Jul 31, 2025: Shares held short 749.4K
  • Aug 15, 2025: Shares held short 700.3K
  • Aug 29, 2025: Shares held short 442.1K
  • Sep 15, 2025: Shares held short 488.1K
  • Sep 30, 2025: Shares held short 220.2K
  • Oct 15, 2025: Shares held short 96.2K
  • Oct 31, 2025: Shares held short 198.9K
  • Nov 14, 2025: Shares held short 77.8K
  • Nov 28, 2025: Shares held short 91.1K
  • Dec 15, 2025: Shares held short 137.5K
  • Dec 31, 2025: Shares held short 145.5K
  • Jan 15, 2026: Shares held short 53.5K
  • Jan 30, 2026: Shares held short 105.8K
  • Feb 13, 2026: Shares held short 119.5K
  • Feb 27, 2026: Shares held short 335.5K
  • Mar 13, 2026: Shares held short 149.5K
  • Mar 31, 2026: Shares held short 159.8K
  • Apr 15, 2026: Shares held short 510.1K
  • Apr 30, 2026: Shares held short 622.2K
  • May 15, 2026: Shares held short 976.7K
  • May 29, 2026: Shares held short 890.3K
  • Jun 15, 2026: Shares held short 2.34M
  • Jun 30, 2026: Shares held short 4.74M
  • Jul 15, 2026: Shares held short 5.60M
  • Jul 31, 2026: Shares held short 4.08M
  • Aug 14, 2026: Shares held short 3.80M
  • Aug 31, 2026: Shares held short 4.08M
  • Sep 15, 2026: Shares held short 3.02M
  • Sep 30, 2026: Shares held short 2.56M
  • Oct 15, 2026: Shares held short 2.29M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading53.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 53.5% of the shares in the reported trades were short sales, against 49.5% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
53.5%
The 14 beforeOct 13, 2026 – Oct 30, 2026
49.5%
Change
+4.0 pts
Short sales a dayon average, of 1.07M shares
571.0K
More than atof 3,666 US-listed companies, same days
61%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 47.2%
  • Oct 14, 2026: Short sales 37.1%
  • Oct 15, 2026: Short sales 36.7%
  • Oct 16, 2026: Short sales 59.9%
  • Oct 19, 2026: Short sales 74.3%
  • Oct 20, 2026: Short sales 54.6%
  • Oct 21, 2026: Short sales 55.2%
  • Oct 22, 2026: Short sales 25.4%
  • Oct 23, 2026: Short sales 58.2%
  • Oct 26, 2026: Short sales 54%
  • Oct 27, 2026: Short sales 46%
  • Oct 28, 2026: Short sales 44%
  • Oct 29, 2026: Short sales 61.1%
  • Oct 30, 2026: Short sales 51.8%
  • Nov 2, 2026: Short sales 34.5%
  • Nov 3, 2026: Short sales 44.2%
  • Nov 4, 2026: Short sales 41.4%
  • Nov 5, 2026: Short sales 36.5%
  • Nov 6, 2026: Short sales 65.8%
  • Nov 9, 2026: Short sales 35.8%
  • Nov 10, 2026: Short sales 63%
  • Nov 11, 2026: Short sales 56.3%
  • Nov 12, 2026: Short sales 67.3%
  • Nov 13, 2026: Short sales 53.6%
  • Nov 16, 2026: Short sales 67.7%
  • Nov 17, 2026: Short sales 69.1%
  • Nov 18, 2026: Short sales 61.8%
  • Nov 19, 2026: Short sales 66.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

17.47M Insiders' shares34.37% Of the company
  • Grigorios SiokasChief Executive Officer
    Directly14.60M
  • Georgios TerzisChief Financial Officer
    Directly2.56M
  • Anastasios AslidisDirector
    Directly100.0K
  • Suhel BhutawalaDirector
    Directly65.0K
  • Demetrios G. DemetriadesSecretary
    Directly55.0K
  • John James HoidasDirector
    Directly50.0K
  • Theodoros Christos KarkantzosDirector
    Directly35.0K

A lower bound: it counts only the 7 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

20 Managers, Q2 2026$389.5K Value of their positions
  • Q3 2025: Managers 22
  • Q4 2025: Managers 21
  • Q1 2026: Managers 21
  • Q2 2026: Managers 20

Institutional investors by quarter

The fund managers holding COSM, quarter by quarter, from Q4 2020 to Q2 2025, 15 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 20 managers held 2.11M shares, worth $389.5K. During the quarter 5 opened a position, 6 closed one, 5 added and 4 trimmed.

The largest holders, Q2 2026

  • UBS Group
    In the quarter×46.7
  • Vanguard Fiduciary Trust
    In the quarter+249%
  • Jane Street Group
    In the quarter
  • Geode Capital Management
    In the quarter-11%
  • BlackRock
    In the quarter
  • Vanguard Capital Management
    In the quarter+24%
  • Northern Trust
    In the quarter+162%
  • State Street
    In the quarter
  • Sassicaia Capital Advisers
    In the quarter
  • Kestra Private Wealth Services
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Cosmos Health's filings show?

Who buys and sells is one part of Cosmos Health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about COSM's shareholders

Didn't find what you were looking for?

Ask us
Have COSM's insiders bought or sold?

From Jun 11, 2026 to Jul 31, 2026 Cosmos Health's insiders bought $457.0K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.